UNSPSC 51282908: Cadrofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C19H20F3N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1YOQ7J9ACY, chemically known as 128427-55-4 (monohydrochloride, s isomer) but generally known as cadrofloxacin, which bears US NIH Compound Identifier 189912. The term CADROFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). Most nations schedule cadrofloxacin under HS 29335995 and SITC 51576.

As of Q4 2014, CADROFLOXACIN remains the US FDA Preferred Term for this commodity. Cadrofloxacin bears US NLM identifiers UMLS ID C1454081 and NCI Concept Code C76229. SMILES: CC1CN(CCN1)C2=C(C=C3C(=C2OC(F)F)N(C=C(C3=O)C(=O)O)C4CC4)F.

UNSPSC 51282908 Cadrofloxacin is a Commodity code that does not reflect the actual work state and local governments are buying under this taxonomy entry. Recent opportunities posted against this code involve naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products for state and local health systems, and exploratory procurement for direct-to-manufacturer prescription programs — none of which correspond to cadrofloxacin, a specific fluoroquinolone antibiotic. The code designation appears to be a misalignment between how state and local procurement offices have tagged these opportunities and the taxonomy's narrow definition. State and local governments purchasing under or near this space are acquiring a broad range of pharmaceutical products and medical supplies to support emergency response, public health initiatives, employee health plans, and community health programs, typically through cooperative purchasing vehicles or direct competitive bidding.

Issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local members including Oregon). Recent opportunities span Florida, Texas, Minnesota, and Oregon, with activity driven by cooperative purchasing frameworks and state procurement offices. Representative recent solicitations include Seminole County's IFB60459723LAS for naloxone and drug deactivation systems (due July 26, 2023, for annual procurement); Tampa's invitation to bid 26P00145 for medical and first aid supplies to the Fire Department Rescue Division (due March 13, 2026, estimated contract value $700,000, SLBE-sheltered with a 5 percent bid discount); and MMCAP's RFP S1070000015802 for generic pharmaceuticals and OTC products across multiple state and local members (responses due March 26, 2026). The code shows little relevant recent activity when narrowly interpreted as cadrofloxacin specifically, but demonstrates consistent procurement demand for pharmaceutical products and medical supplies across state and local health and emergency-response agencies when read as a broader family of health-sector purchases.